BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 9344718)

  • 1. Phase-directed therapy and cardiac xenograft survival.
    Lin H; Gastman BR; Wei RQ; Kunkel SL; Gordon D; Bolling SF
    J Surg Res; 1997 Sep; 72(1):84-8. PubMed ID: 9344718
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Leflunomide prolongs pulmonary allograft and xenograft survival.
    Yuh DD; Gandy KL; Morris RE; Hoyt G; Gutierrez J; Reitz BA; Robbins RC
    J Heart Lung Transplant; 1995; 14(6 Pt 1):1136-44. PubMed ID: 8719461
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination therapy with Brequinar sodium and cyclosporine synergistically prolongs hamster-to-rat cardia xenograft survival.
    Cosenza CA; Cramer DV; Tuso PJ; Chapman FA; Wang HK; Makowka L
    J Heart Lung Transplant; 1994; 13(3):489-97. PubMed ID: 8061026
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of species-specific host accommodation in the hamster-to-rat xenotransplantation model.
    Yin D; Ma LL; Blinder L; Shen J; Sankary H; Williams JW; Chong AS
    J Immunol; 1998 Aug; 161(4):2044-51. PubMed ID: 9712078
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A new strategy for prolonging xenograft survival.
    Alexander JW; Masroor S; Levy A; Galla K
    Transplantation; 1994 Jul; 58(1):14-7. PubMed ID: 8036704
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pre-transplant blood transfusion and cyclosporin A induce long-term hamster cardiac xenograft survival in immunocompetent rats.
    Vriens PW; Stoot JH; van der Steenhoven TJ; Hoyt G; Bouwman E; Robbins RC
    Xenotransplantation; 2005 Jan; 12(1):63-71. PubMed ID: 15598275
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Control and reversal of chronic xenograft rejection in hamster-to-rat cardiac transplantation.
    Xiao F; Shen J; Chong A; Liu W; Foster P; Blinder HL; Sankary H; McChesney L; Mital D; Williams JW
    Transplant Proc; 1996 Apr; 28(2):691-2. PubMed ID: 8623348
    [No Abstract]   [Full Text] [Related]  

  • 8. Synergistic activity of malononitrilamides with cyclosporine to control and reverse xenograft rejection.
    Schorlemmer HU; Kurrle R
    Int J Tissue React; 1997; 19(3-4):149-56. PubMed ID: 9506316
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Accommodation and T-independent B cell tolerance in rats with long term surviving hamster heart xenografts.
    Lin Y; Vandeputte M; Waer M
    J Immunol; 1998 Jan; 160(1):369-75. PubMed ID: 9551993
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of cyclosporine alone or in combination with rapamycin and brequinar on survival of hamster heart xenograft in rats.
    Wang M; Tu Y; Stepkowski SM; Kahan BD
    Transplant Proc; 1993 Oct; 25(5):2876-7. PubMed ID: 8212271
    [No Abstract]   [Full Text] [Related]  

  • 11. Evaluation of tetrahydropyranyladriamycin as an immunosuppressant in concordant xenotransplantation.
    Yasutomi M; Hayashi S; Ito M; Ohtsuka S; Namii Y; Uchida K; Yokoyama I; Takagi H
    J Heart Lung Transplant; 1997 Mar; 16(3):283-9. PubMed ID: 9087871
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prolonged xenograft survival following combination therapy with brequinar sodium and cyclosporine.
    Cosenza CA; Tuso PJ; Chapman FA; Middleton YD; Cramer DV; Wu GD; Makowka L
    Transplant Proc; 1993 Jun; 25(3 Suppl 2):59-60. PubMed ID: 8516946
    [No Abstract]   [Full Text] [Related]  

  • 13. Efficacy of rapamycin, RS-61443 and cyclophosphamide in the prolongation of survival of discordant pig to rabbit cardiac xenografts.
    Yatscoff RW; Wang S; Keenan R; Chackowsky P; Lowes N; Koshal A
    Can J Cardiol; 1994 Sep; 10(7):711-6. PubMed ID: 7922826
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunosuppressive effects of leflunomide in a cardiac allograft model.
    Williams JW; Xiao F; Foster PF; Chong A; Sharma S; Bartlett R; Sankary HN
    Transplant Proc; 1993 Feb; 25(1 Pt 1):745-6. PubMed ID: 8438465
    [No Abstract]   [Full Text] [Related]  

  • 15. Graft adaptation in hamster-to-rat cardiac xenografts.
    Hasan RI; Sriwatanawangosa V; Wallwork J; White DJ
    Transplant Proc; 1994 Jun; 26(3):1282-3. PubMed ID: 8029909
    [No Abstract]   [Full Text] [Related]  

  • 16. Cyclosporine dosage can be reduced when used in combination with an anti-intercellular adhesion molecule-1 monoclonal antibody in rats undergoing heterotopic heart transplantation.
    Harrison PC; Mainolfi E; Madwed JB
    J Heart Lung Transplant; 1998 Feb; 17(2):150-7. PubMed ID: 9513853
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A short course of cyclosporine immunosuppression inhibits rejection but not tolerance of rat liver allografts.
    Huang WH; Yan Y; De Boer B; Bishop GA; House AK
    Transplantation; 2003 Feb; 75(3):368-74. PubMed ID: 12589161
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protective mechanisms of a metalloporphyrinic peroxynitrite decomposition catalyst, WW85, in rat cardiac transplants.
    Pieper GM; Nilakantan V; Chen M; Zhou J; Khanna AK; Henderson JD; Johnson CP; Roza AM; Szabó C
    J Pharmacol Exp Ther; 2005 Jul; 314(1):53-60. PubMed ID: 15784653
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reevaluation of total-lymphoid irradiation and cyclosporine therapy in the Syrian hamster-to-Lewis rat cardiac xenograft model.
    DeMasi R; Alqaisi M; Araneda D; Nifong W; Thomas J; Gross U; Swanson M; Thomas F
    Transplantation; 1990 Mar; 49(3):639-41. PubMed ID: 2180153
    [No Abstract]   [Full Text] [Related]  

  • 20. Leflunomide and cyclosporine immunomodulation in intestinal xenotransplantation.
    Foster PF; Kociss K; Shen J; Sankary HN; Xiao F; Williams JW
    Transplant Proc; 1996 Oct; 28(5):2527-8. PubMed ID: 8907935
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.